Cytogenetic abnormalities detected by fluorescence in situ hybridization on paraffin-embedded chronic lymphocytic leukemia/small lymphocytic lymphoma lymphoid tissue biopsy specimens

American Journal of Clinical Pathology

Volumn 130, Issue 4, 2008, Pages 620-627

  Flanagan, Melina B ^a   Sathanoori, Malini ^a   Surti, Urvashi ^a   Soma, Lorinda ^a   Swerdlow, Steven H ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

B cell lymphomas; Chronic lymphocytic leukemia; Cytogenetics; Fluorescence in situ hybridization; Prognosis; Small lymphocytic lymphoma

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 11Q; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTOMA; LYMPHOID TISSUE; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TRISOMY; B CELL LEUKEMIA; BIOPSY; GENETICS; MIDDLE AGED;

PARAFFIN;

ADULT; AGED; BIOPSY; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PARAFFIN EMBEDDING;

EID: 54049138033     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/H9AREV6E2JTMEC6J     Document Type: Article

References (32)

1. Shanafelt TD, Call TG. Current approach to diagnosis and management of chronic lymphocytic leukemia. Mayo Clinic Proc. 2004;79:388-398.
2. Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46:219-234.
3. Binet J, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981;48:198-206.
4. Nelson BP, Gupta R, Dewald GW, et al. Chronic lymphocytic leukemia FISH panel: impact on diagnosis. Am J Clin Pathol. 2007;128:323-332.
5. Reddy KS. Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel. Br J Haematol. 2006;132:705-722.
6. Ripolles L, Ortega M, Ortuno F, et al. Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2006;171:57-64.
7. Sindelarova L, Michalova K, Zemanova Z, et al. Incidence of chromosomal anomalies detected with FISH and their clinical correlations in B-chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2005;160:27-34.
8. Glassman AB, Hayes KJ. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2005;158:88-91.
9. Aoun P, Blair HE, Smith LM, et al. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Lymphoma. 2004;45:1595-1603.
10. Goorha S, Glenn MJ, Drozd-Borysiuk E, et al. A set of commercially available fluorescent in-situ hybridization probes efficiently detects cytogenetic abnormalities in patients with chronic lymphocytic leukemia. Genet Med. 2004;6:48-53.
11. Dewald GW, Brockman SR, Paternoster SF, et al. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia. Br J Haematol. 2003;121:287-295.
12. Krober A, Seiler T, Benner A, et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood. 2002;100:1410-1416.
13. Jarosova M, Jedlickova K, Holzerova M, et al. Contribution of comparative genomic hybridization and fluorescence in situ hybridization to the detection of chromosomal abnormalities in B-cell chronic lymphocytic leukemia. Onkologie. 2001;24:60-65.
14. Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343:1910-1916.
15. Dohner H, Stilgenbauer S, James MR, et al. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood. 1997;89:2516-2522.
16. Stilgenbauer S, Bullinger L, Benner A, et al. Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia. Leukemia. 1999;13:1331-1334.
17. Offit K, Louie D, Parsa N, et al. Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21q23). Blood. 1994;83:2611-2618.
18. Juliusson G, Oscier D, Gahrton G; for the International Working Party on Chromosomes in CLL (IWCCLL). Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia: second IWCCLL compilation of data on 662 patients. Leuk Lymphoma. 1991;5:21-25.
19. Cuneo A, Rigolin GM, Bigoni R, et al. Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis. Leukemia. 2004;18:476-483.
20. Oscier DG, Stevens J, Hamblin TJ, et al. Correlation of chromosome abnormalities with laboratory features and clinical course in B-cell chronic lymphocytic leukaemia. Br J Haematol. 1990;76:352-358.
21. Zhang Y, Weber-Matthiesen K, Siebert R, et al. Frequent deletions of 6q23-24 in B-cell non-Hodgkin's lymphomas detected by fluorescence in situ hybridization. Genes Chromosomes Cancer. 1997;18:310-313.
22. Muller-Hermelink HK, Catovsky D, Montserrat E, et al. Chronic lymphocytic leukaemia/small lymphocytic lymphoma. In: Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:127-130. World Health Organization Classification of Tumours.
23. Paternoster SF, Brockman SR, McClure RF, et al. A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization. Am J Pathol. 2002;160:1967-1972.
24. Barrans SL, Evans PAS, O'Connor SJM, et al. The detection of t(14;18) in archival lymph nodes: development of a fluorescence in situ hybridization (FISH)-based method and evaluation by comparison with polymerase chain reaction. J Mol Diagn. 2003;5:168-175.
25. Sherer ME, Shekhter-Levin S, Krause JR, et al. Atypical (7;19) translocation in acute myelomonocytic leukemia. Cancer Genet Cytogenet. 1991;57:169-173.
26. Nowakowski GS, Dewald GW, Hoyer JD, et al. Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. Br J Haematol. 2005;130:36-42.
27. Soma LA, Gollin SM, Remstein ED, et al. Splenic small B-cell lymphoma with IGH/BCL3 translocation. Hum Pathol. 2006;37:218-230.
28. Huh YO, Abruzzo LV, Rassidakis GZ, et al. The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases. Br J Haematol. 2007;136:220-228.
29. Martin-Subero JI, Ibbotson R, Klapper W, et al. A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation. Leukemia. 2007;21:1532-1544.
30. Dyer MJ, Oscier DG. The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia. Leukemia. 2002;16:973-984.
31. Liso V, Capalbo S, Lapietra A, et al. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia. Haematologica. 1999;84:212-217.
32. Garcia-Marco JA, Price CM, Catovsky D. Interphase cytogenetics in chronic lymphocytic leukemia. Cancer Genet Cytogenet. 1997;94:52-58.